Literature DB >> 31394711

Stathmin in Cell Proliferation and Cancer Progression.

G V Sherbet1,2, F Cajone3.   

Abstract

The phosphoprotein stathmin exerts profound influences on cell proliferation, differentiation and in cell motility. These phenotypic features are displayed in response to specific signals imparted to the cell by biological response modifiers. Stathmin functions as a focal point in co-ordinating and directing the cellular signals into specific and defined pathways. Two biological features that characterise cancer are the deregulation of cell proliferation leading to tumour growth and invasive behaviour. Stathmin is up-regulated in many neoplasms and the modulation of its expression correlates with invasion and metastasis and highly proliferating normal tissues. The integrity of the transduction of extracellular signals is essential for the normal functioning of the cellular machinery in cell differentiation, morphogenesis and cell proliferation, apoptosis, growth and senescence. Stathmin mediates these pathways of signalling. Stathmin has been implicated in both G1-S and G2-M checkpoint control of cell cycle progression by influencing the dynamics of microtubule formation and progression of the cell cycle. Stathmin appears to exert its regulatory effects at both G1-S and G2-M checkpoints by interacting with other cell cycle control proteins such as p53 and rb and with cancer metastasis promoting or inhibiting genes as well as other proteins such as heat shock proteins. Stathmin co-ordinates the signalling by extracellular matrix proteins, and defines intercellular adhesion and cell motility. Therefore, the deregulation of stathmin function would have profound implications in the pathogenesis and progression of cancer. Copyright
© 2005 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cancer progression; S100A4; cell cycle regulation; cell motility; cell proliferation; extracellular matrix; growth factors; heat shock proteins; invasion; metastasis; microtubule dynamics; nm23; prognosis; review; signal transduction; suppressor genes; tumour promoter genes

Year:  2005        PMID: 31394711

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  2 in total

1.  Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma.

Authors:  Andrew T Turk; Dario Garcia-Carracedo; David T Kent; Elizabeth Philipone; Juana Maria Garcia-Pedrero; Salvatore M Caruana; Lanny G Close; Gloria H Su
Journal:  Genes Dis       Date:  2020-12-13

2.  Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.

Authors:  Safiah Ibrahim Althurwi; Jun Q Yu; Philip Beale; Fazlul Huq
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.